Glomeria Therapeutics is a company specialized in research and development.
Our mission is to deliver hospital products, drugs and medical therapy devices to patients with severe forms of nephropathy and cardiopathy.
It is Glomeria Therapeutics’ policy to keep infrastructure costs to a minimum whilst maximizing access to scientific knowledge and research in the biomedical field. Therefore, all the creative and development phases that go into identifying new therapy targets (pre-clinical pharmacology, applied engineering, prototype
building, etc) are conducted in-house, while the industrial development is farmed out to service firms specialized in the target sectors.
The management of Glomeria Therapeutics draws on a group of professionals with high qualification in research and development for pharmaceutical products and medical devices. As a whole the company management and scientific board can count on a solid experience in all branches of the pharmaceutics and medical apparatus.
Location: Italy, Abruzzo, Chieti
Member count: 11-50
Total raised: $1.130588M
Founded date: 2010
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 19.09.2015 | - | $1.130588M | - | finsmes.co... |
Mentions in press and media 1
| Date | Title | Description | Category | Author | Source |
| 19.09.2015 | Glomeria T... | Glomeria Therapeutics, a Chiet... | Italy | - | finsmes.co... |